Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Khouri

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Annals of Internal Medicine|November 1, 1996
Allogenic bone marrow transplantation in chronic lymphocytic leukemiaI Khouri, R Champlin
Cancer Treatment and Research|May 9, 2000
Non myeloablative "mini transplants"S Giralt, I Khouri, R Champlin
Pediatric Transplantation|December 10, 1999
Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modalityR Champlin, I Khouri, S Giralt
Journal of Clinical Apheresis|June 4, 1999
Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseasesR Champlin, I Khouri, S Giralt
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effectA Shimoni, S Giralt, I Khouri, et al.
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimensR Champlin, van Besien K, S Giralt, et al.
Oncology (Williston Park, N.Y.)|June 5, 1999
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effectR Champlin, I Khouri, S Komblau, et al.
Current Opinion in Oncology|April 3, 1999
Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancyR Champlin, I Khouri, S Kornblau, et al.
American Journal of Hematology|January 10, 1998
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty casesD Przepiorka, S Giralt, I Khouri, et al.
Bone Marrow Transplantation|February 18, 1998
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantationM Woo, D Przepiorka, C Ippoliti, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Annals of Internal Medicine|November 1, 1996
Allogenic bone marrow transplantation in chronic lymphocytic leukemiaI Khouri, R Champlin
Cancer Treatment and Research|May 9, 2000
Non myeloablative "mini transplants"S Giralt, I Khouri, R Champlin
Pediatric Transplantation|December 10, 1999
Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modalityR Champlin, I Khouri, S Giralt
Journal of Clinical Apheresis|June 4, 1999
Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseasesR Champlin, I Khouri, S Giralt
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effectA Shimoni, S Giralt, I Khouri, et al.
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimensR Champlin, van Besien K, S Giralt, et al.
Oncology (Williston Park, N.Y.)|June 5, 1999
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effectR Champlin, I Khouri, S Komblau, et al.
Current Opinion in Oncology|April 3, 1999
Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancyR Champlin, I Khouri, S Kornblau, et al.
American Journal of Hematology|January 10, 1998
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty casesD Przepiorka, S Giralt, I Khouri, et al.
Bone Marrow Transplantation|February 18, 1998
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantationM Woo, D Przepiorka, C Ippoliti, et al.
Pageof 8